Headaches are often the first symptom of brain cancer; other symptoms include difficulty speaking or remembering words, disturbed vision, hearing, smell or taste, seizures, weakness or paralysis in part of the body, loss of balance, general irritability, drowsiness or change in personality, nausea or vomiting.
Known risk factors for developing brain cancer include exposure to radiation, age, family history and exposure to industrial chemicals and is more common in men.
Treatment of brain cancer is based on the location, size, and grade of the tumour and may include surgery, radiotherapy, chemotherapy and steroids to reduce swelling in the brain. Surgery and radiotherapy are the primary treatments of brain cancer.
There is growing interest in the role of clinical nutrition in adjunctive care for brain cancers as recent evidence has shown a link between low folate levels and brain cancer.
Studies into Glioblastoma multiforme (GBM) have suggested that folate supplementation may limit the growth of glioblastoma and may increase the sensitivity of cancer cells to Temozolamide – a chemotherapy agent administered to patients with GBM.
The ReMed Oncology team provides an individually tailored, integrative and supportive treatment program designed around your specific situation. It is an adjunctive care model meaning we work alongside your conventional treatment.
Our Ancora oncology team offers a complimentary 20-minute & consult to answer any questions and work out whether this approach is right for you. The complimentary appointment can be booked online or by phoning our ReMed clinics on 1300 1 REMED.